
High CPAP adherence also resulted in a significant protective effect on the 30-day readmission for beneficiaries with heart failure.

High CPAP adherence also resulted in a significant protective effect on the 30-day readmission for beneficiaries with heart failure.

Patients with IBD were approximately 3.5 times more likely to have moderate or severe periodontitis.

New EADV data suggest clinicians may need to uniquely treat patients with adult-onset eczema based on inflammatory pathways.

The approval is based on data from 2 clinical trials showing the agent improved the rate of post-operation patients avoiding sickness by 50%.

A draft report released from the Institute for Clinical and Economic Review (ICER) compared the benefits of etranacogene dezaparvovec (EtranaDez) and valoctocogene roxaparvovec (val-rox) to current treatments.

New data, alongside any future research operating from a family systems approach can provide novel insight into sleep, mental health, and attachments.

Lifestyle interventions increased weight-specific quality of life in Latino youth with diabetes compared with usual care.

Children regularly engaged in physical activities had significantly better visual and stereoacuity than those who reported moderate, light or no activity.

The inter-relationship of HPCs, HSCs, and macrophages was influenced by the stage of fibrosis, but not BMI.

The increase in EoE incidence was most pronounced in men and for patients aged 40 years and older.

In this episode of Don’t Miss a Beat, hosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, provide a recap of the European Society of Cardiology Congress 2022. This recap begins with a discussion on the results of the phase 3 DELIVER trial, in which Vaduganathan served as an investigator, the ADVOR trial, and REVIVED.

People with diabetes in Italy and the UK reported the highest rates of anxiety at 63% and 51%, respectively.

Children identifying as Black, Mexican American, low-income, or non-US citizen were more likely to report poor subjective visual function from 2005 to 2008.

The investigators sequenced HBsAg and found no amino acid substitution.

Patients with pulmonary tuberculosis (TB) exhibited an improvement in quality of life and a reduction in treatment costs by utilizing a digital medication event reminder monitor (MERM).

It is the first FDA-approved product indicated to improve kidney function in adults with HRS.

There has been a significant increase of IBD overall and Crohn’s disease specifically in pediatric patients between 2000-2014.

Dr. Sara Mednick's pursuit to understand how to improve intelligence led her to an extensive career of studying the various mechanisms of sleep.

Model results were sensitive to the probability of hernia recurrence and hernia incarceration and utility decrement in the symptomatic hernia state.

There was a 25% relative reduction and a 0.3% absolute reduction in prevalence-adjusted index surgery rates for Crohn’s disease between 2007-2016.

Short-term treatment with rosuvastatin was not linked to changes in insulin resistance markers in a cohort of children with familial hypercholesterolemia.

Individuals were more likely to communicate about sleep during depressed mood episodes.

Dr. Mednick's latest book, The Power of the Downstate, focuses on the integrated role of sleep by following the "rhythm of upstates and downstates" that people operate in every day.

Cases and hospitalizations due to EV-D68, a rare form of enterovirus associated with acute flaccid myelitis (AFM), have been increasing among children across the country.

Study data suggest the observed to expected ratio of VAU for the United States cases reports was comparable for all 3 approved vaccines.

Individuals who reported three cumulative insomnia symptoms of DIS, DSM and NRS had 40% increased risk of future bloodstream infection.

Patients with both COVID-19 and HBV had a significantly higher in-hospital mortality rate and were more likely to develop severe disease compared to patients with only COVID-19 infections.

Malnutrition rates were similar between patients with ulcerative colitis and patients with Crohn’s disease.

Nonpharmacological sleep interventions that focused on earlier sleep schedules can serve as a “simple, pragmatic, effective way to meaningfully increase sleep duration that could have important benefits for child health.”

Acadia Pharmaceuticals announced that the FDA granted a priority review for trofinetide and set March 12, 2023 as the PDUFA date.